Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|November 21, 2022
NKB cells: A double-edged sword against inflammatory diseasesNikunj Tandel, Sushmita Negi, Rajeev K Tyagi
International Reviews of Immunology|February 2, 2023
Role of natural killer and B cell interaction in inducing pathogen specific immune responsesNikunj Tandel, Sushmita Negi, Sarat K Dalai, et al.
Drug Discovery Today|June 17, 2023
Aceclofenac and methotrexate combination therapy could influence Th1/Th17 axis to modulate rheumatoid-arthritis-induced inflammationSushmita Negi, Nikunj Tandel, Prakriti Sharma, et al.
Frontiers in Pharmacology|September 12, 2022
Corrigendum: Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseasesNeeraj K Garg, Nikunj Tandel, Sanjay Kumar Bhadada, et al.
Frontiers in Pharmacology|October 7, 2021
Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory DiseasesNeeraj K Garg, Nikunj Tandel, Sanjay Kumar Bhadada, et al.
STAR Protocols|June 21, 2024
Protocol for oleuropein-induced autophagy mediating drug tolerance in P. falciparumSonia Devi, Sushmita Negi, Prakriti Sharma, et al.
Drug Discovery Today|November 28, 2024
Oleuropein: a viable therapeutic option for malaria and cancerSonia Devi, Sushmita Negi, Nikunj Tandel, et al.
Current Drug Targets|April 7, 2018
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti- Diabetic and Anti-Hyperlipidemic EffectsNaisargee Patel, Rajeev K Tyagi, Nikunj Tandel, et al.
Frontiers in Microbiology|September 4, 2024
Oleuropein mediated autophagy begets antimalarial drug resistancePrakriti Sharma, Neil Roy Chaudhary, Sonia Devi, et al.
Heliyon|March 8, 2024
Poly(I:C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen(s)Nikunj Tandel, Digna Patel, Mansi Thakkar, et al.
Pageof 3